|
Consolidated Statement of Cash Flows (USD $)
In Thousands, unless otherwise specified
|
3 Months Ended |
|
Mar. 31, 2015
|
Mar. 31, 2014
|
| Operating activities |
|
|
| Net loss |
$ (10,027) |
$ (5,629) |
| Adjustments to reconcile net loss to net cash provided by operating activities |
|
|
| Depreciation and amortization expense |
4,799 |
2,520 |
| Stock-based compensation expense |
22,247 |
7,963 |
| Excess tax benefit from stock-based compensation |
(324) |
(3,329) |
| Deferred income taxes |
(2,571) |
3,381 |
| Changes in operating assets and liabilities |
|
|
| Accounts receivable, net |
14,514 |
10,655 |
| Prepaid expenses, deposits and other assets |
(1,078) |
92 |
| Income taxes receivable |
(25) |
(36) |
| Deferred revenue |
9,219 |
3,953 |
| Accounts payable and accrued liabilities |
(1,784) |
(5,172) |
| Income taxes payable |
34 |
(72) |
| Net cash provided by operating activities |
35,004 |
14,326 |
| Investing activities |
|
|
| Purchase of property and equipment |
(7,620) |
(3,708) |
| Net cash used in investing activities |
(7,620) |
(3,708) |
| Financing activities |
|
|
| Proceeds from public offering, net of underwriters' discount and offering costs |
0 |
344,386 |
| Proceeds from exercise of stock options |
8,348 |
5,477 |
| Excess tax benefit from stock-based compensation |
324 |
3,329 |
| Net cash provided by financing activities |
8,672 |
353,192 |
| Effect of exchange rate changes on cash and cash equivalents |
(1,005) |
24 |
| Net increase in cash and cash equivalents |
35,051 |
363,834 |
| Cash and cash equivalents |
|
|
| Beginning of period |
680,613 |
252,674 |
| End of period |
715,664 |
616,508 |
| Non-cash activities |
|
|
| Accrued purchases of property and equipment |
6,360 |
2,595 |
| Deferred public offering cost accruals |
0 |
350 |
| Asset retirement obligations recognized |
$ 304 |
$ 0 |